US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
ETF
アメリカ
AMEX
Fidelity Enhanced Large Cap Value ETF (FELV)
Fidelity Enhanced Large Cap Value ETF (FELV) オプション

Fidelity Enhanced Large Cap Value ETF (FELV)

38.99

-0.83

(-2.08%)

終了 6月7日 5:00AM

39.06

0.07

(0.18%)

取引時間後: 8:59AM

Fidelity Enhanced Large Cap Value ETF ([symbol]) オプションチェーン

FELV ライブオプションフロー

オプションコール

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
29.00	8.20	12.10	0.00	10.15	0.00	0.00 %	0	0	-
30.00	7.20	11.10	0.00	9.15	0.00	0.00 %	0	0	-
31.00	6.20	10.10	0.00	8.15	0.00	0.00 %	0	0	-
32.00	5.20	9.10	0.00	7.15	0.00	0.00 %	0	0	-
33.00	4.20	8.10	0.00	6.15	0.00	0.00 %	0	0	-
34.00	3.20	7.10	0.00	5.15	0.00	0.00 %	0	0	-
35.00	2.20	6.10	0.00	4.15	0.00	0.00 %	0	0	-
36.00	1.20	5.10	0.00	3.15	0.00	0.00 %	0	0	-
37.00	0.20	4.10	2.74	2.15	0.80	41.24 %	2	2	2026/6/06
38.00	0.00	3.20	1.41	1.41	0.00	0.00 %	0	1	-
39.00	0.00	2.40	0.00	0.00	0.00	0.00 %	0	0	-
40.00	0.00	1.95	0.00	0.00	0.00	0.00 %	0	0	-
41.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
42.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-
43.00	0.00	1.85	0.00	0.00	0.00	0.00 %	0	0	-

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

オプションプット

行使価格	買値	売値	前回の価格	中間価格	前日比	前日比 %	出来高	建玉	最終取引
29.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
30.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
31.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
32.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
33.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
34.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
35.00	0.00	1.90	0.00	0.00	0.00	0.00 %	0	0	-
36.00	0.00	1.95	0.00	0.00	0.00	0.00 %	0	0	-
37.00	0.00	1.95	0.00	0.00	0.00	0.00 %	0	0	-
38.00	0.00	2.05	0.00	0.00	0.00	0.00 %	0	0	-
39.00	0.00	2.35	0.00	0.00	0.00	0.00 %	0	0	-
40.00	0.00	3.00	0.00	0.00	0.00	0.00 %	0	0	-
41.00	0.05	4.00	0.00	2.025	0.00	0.00 %	0	0	-
42.00	1.05	5.00	0.00	3.025	0.00	0.00 %	0	0	-
43.00	2.05	6.00	0.00	4.025	0.00	0.00 %	0	0	-

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
SCAGScage Future	US$ 0.8489 (196.61%)	92.75M
SPHLSpringview Holdings Ltd	US$ 5.38 (125.20%)	40.61M
NOTVInotiv Inc	US$ 0.1638 (89.15%)	1.07B
RMSGReal Messenger Corporation	US$ 1.809 (64.45%)	199.97M
STISolidion Technology Inc	US$ 35.50 (56.32%)	38.55M
NUWENewellis Inc	US$ 0.1625 (-62.30%)	50M
NYXHNyxoah SA	US$ 1.41 (-51.04%)	2.47M
CYPHCypherpunk Technologies Inc	US$ 0.5176 (-47.26%)	30.53M
TDICDreamland Ltd	US$ 0.2277 (-37.68%)	12.09M
FOFOHang Feng Technology Innovation Co Ltd	US$ 3.91 (-36.73%)	381.9k
NOTVInotiv Inc	US$ 0.1638 (89.15%)	1.07B
SNBRSleep Number Corporation	US$ 0.477 (36.25%)	305.13M
SMTKSmartKem Inc	US$ 0.419101 (30.97%)	232.19M
NVDANVIDIA Corporation	US$ 205.10 (-6.20%)	220.65M
RMSGReal Messenger Corporation	US$ 1.809 (64.45%)	199.97M

DTGoody

DTGoody 4分前

Yes, I was playing that Damn VMH* which appears I jinxed as usual! That's another one pissing me off! LOL I could have bought a ton more shares here if I reacted better to the news and switched things around if you know what I mean. Instead, I had my thumb up my Rear while this Gem keeps running! LO

Myth

Hand Of Fate · The Rolling Stones

https://www.youtube.com/watch?v=3RGhtDjup38

badshah

badshah 5分前

School teacher...but you have no shares...so why the interest????

dewophile

dewophile 5分前

I’ll check it out thanks. A key point is that ketones can rise even when glucose levels are within range. I’m not sure the commercial opportunity but it sounds not only limited to type 1 diabetics. It also seems like dexcom has greater market share in intensive insulin users and this is the populati

Myth

The Rolling Stones - One Hit (To The Body)

https://www.youtube.com/watch?v=dx2WRQLSIew

1plus1

A Once in a lifetime opportunity, BIEI will make history next week in Mexico, World Cup and we sponsor the product … possible dream come true

jerkviewer

jerkviewer 6分前

i would love to know what he thinks our chances are

jerkviewer

jerkviewer 7分前

it might not be such a longshot....it definitely would change the valuation....nas will hopefully expand on that topic on the cc

eur06

ok it’ll be fine to wait, no rush from me.
GLND

1plus1

1plus1 11分前

LET'S HOPE THEY WILL USE THE PRODUCTS IN FIFFA CUP NEXT WEEK >> THIS WILL BE SWEEEEEEEEEEET AND OVER .10+ CENTS

FOFreddie

FOFreddie 11分前

Ackman is a billionaire friend who would probably this resolved ASAP. John Paulson is a billionaire friend who also probably wants this resolved ASAP. They really need to come out with a Housing Plan ASAP as you mentioned. Also - why would Trump want to leave any money on the table for the nex

DTGoody

DTGoody 12分前

Why would Cohen be involved with ENCC??? I'm sorry, but I don't see the connection between him and ENCC.

DTGoody

DTGoody 14分前

We will be on entirely differently exchange then!

flipper44

flipper44 14分前

NWBO was entrusted with this technology well over decades ago. Their perseverance is commendable, but their execution, communication, morphing plans, spending, and red zone efficiency, and that of MHRA, are reasonably subject to scrutiny.

GR8 Dad

GR8 Dad 14分前

If you ride the o t c you're gonna lose some money, even a child knows that.

Make sure your winners are bigger than your losers.That's the only way to play it.

The o t c is the world's largest casino, where the only game is liars poker.

Riding many, many,

Myth

Blow Wind Blow · Eric Clapton

https://www.youtube.com/watch?v=aE-QoPDxijc

DewDiligence

DewDiligence 15分前

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Berobenatide (f/k/a ‘3944) is the lead compound from PFE’s weight-loss pipeline acquired in the Metsera buyout (#msg-176942527).

joe botts

joe botts 16分前

tisdal

tisdal 17分前

Nice Job on the Research CW. That opened my eyes to truly understand what the GARB Report's purpose was. That GARB Report was a preliminary document to establish hydrocarbon potential justifying the 3D Seismic, and after analyzing that data, if drilling would be justifiable.

The sta

FOFreddie

FOFreddie 18分前

The Brydon Fisher lawsuit was a Derivative lawsuit which would have returned the damages back to Fannie and Freddie for the benefit of shareholders. The Lamberth/Berkeley lawsuit is a Class Action but the issue so far is that damages were severely limited. We wait for the Decision on Restitution

DewDiligence

DewDiligence 21分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader 21分前

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence 22分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 22分前

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

Fidelity Enhanced Large ...

National Interstate

Pure Foods Tasmania

Skyward Specialty Insura...

Rubicon Organics (QX)

Deckers Outdoor Dl 01

Triple Flag Precious Met...

Allied Strategic Resource

Global X US 500 ETF

Adavale Resources

Aledade Share Class Leve...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。